TCS, HDFCBANK, SBI Liquid Fund (G)
Ajanta Pharma Ltd.
Ajanta Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Mid-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 30 04 2021 | Audited Results |
| 29 07 2021 | Quarterly Results |
| 29 10 2021 | Interim Dividend & Quarterly Results |
| 28 12 2021 | Buy Back of Shares |
| 31 01 2022 | Quarterly Results |
| 10 05 2022 | Bonus issue & Audited Results |
| 28 07 2022 | Quarterly Results |
| 03 11 2022 | Quarterly Results & Interim Dividend |
| 01 02 2023 | Quarterly Results |
| 10 03 2023 | Buy Back of Shares |
| 05 05 2023 | Audited Results |
| 27 07 2023 | Quarterly Results |
| 27 07 2023 | Interim Dividend & Quarterly Results |
| 31 10 2023 | Quarterly Results |
| 31 01 2024 | Second Interim Dividend & Quarterly Results |
| 28 10 2024 | Quarterly Results |
| 30 01 2025 | Quarterly Results |
| 30 04 2025 | A.G.M. & Audited Results |
News
No News data available
